VDR and pancreatic adenocarcinoma: Anti-macrophage therapy have achieved good therapeutic results clinically, and given the role of VDR on macrophage polarization and recruitment, administering VitD supplementation with anti-macrophage drugs to PAAD patients is expected to provide a new strategy for the clinical management.